EDMONTON, Alberta, June 30, 2023 (GLOBE NEWSWIRE) -- Regenx Tech Corp., (the "Company" or "Regenx") (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN: A2DSW3) has closed the first tranche of its previously announced financing for gross proceeds of $2,113,830. The closing of the first tranche of the offering is subject to all required regulatory approvals, including the acceptance of the Canadian Securities Exchange.
The offering is a non-brokered private placement of unsecured convertible debentures (“Debentures”). The Debentures bear interest at the rate of fifteen percent (15%) per annum and will mature on July 1, 2025. The Debentures will be convertible at the holder’s option into common shares of the Company (“Common Share”) at a conversion price of: (i) $0.105 per Common Share until one (1) year from the closing date; and (ii) $0.15 per Common Share for the period from the date following one (1) year from the closing date until the maturity date. The Corporation can redeem the Debentures at any time upon 10 days prior written notice.
The Company will not be paying finder’s fees in the first tranche closing.
The Company intends to use the proceeds from the offering to further the Catalytic Converter Module One and general working capital purposes.
The Common Shares to be issued under the offering have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States or to a U.S. Persons absent registration or an applicable exemption from the registration. This news release is not an offer or a solicitation of an offer of securities for sale in the United States, nor will there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
For further information contact:
REGENX TECH CORP.
President & CEO